Former Gambian president Yahya Jammeh ordered the massacre of about 30 migrants he said were “mercenaries” sent to topple him in 2005, a member of the former strongman’s hit squad told a truth commission on Tuesday.
The testimony came a day after another army officer accused Jammeh of ordering the murder of a leading journalist who worked for an independent newspaper and wrote articles about the corruption that marked Jammeh’s iron-fisted rule for 22 years.
Omar Jallow, a former officer in the Presidential Guard, said about 45 Europe-bound migrants comprising nationals from Ghana, Nigeria, Senegal and Togo were arrested on a beach while trying to get to Europe.
“Yahya Jammeh ordered for the execution of the foreign nationals,” believing they were mercenaries sent to topple him, Jallow said.
They were taken to a firing range and then the soldiers were told by their commanding officer, Lieutenant Solo Bojang, that the captives were to be killed.
“Solo said these people were mercenaries and he told us that the order from the former head of state [Jammeh] was to fire at them,” he said, adding that the bodies were thrown in a well.
“I was given 100 dollars by one of them who pleaded to me to allow him say his last prayers, but before he completely knelt down [another soldier] fired at him. I used the 100 dollars,” Jallow said.
Human Rights Watch said that the other migrants were also killed.
Jammeh seized power in a bloodless coup in 1994 in the former British colony.
His refusal to leave power after losing a presidential election in 2016 sparked a regional crisis in West Africa, which ended when Jammeh agreed to live in exile in Equatorial Guinea.
The COVID-19 variant discovered in South Africa can “break through” Pfizer-BioNTech’s COVID-19 vaccine to some extent, a real-world data study released on Saturday found, although its prevalence in the country is low and the research has not been peer reviewed. The study in Israel compared almost 400 people who had tested positive for COVID-19, 14 days or more after they received one or two doses of the vaccine, against the same number of unvaccinated people with the disease. It matched age and gender, among other characteristics. The South African variant, B.1.351, was found to make up about 1 percent of all the COVID-19
RARE ADMISSION: A top Chinese expert was the first to publicly address the efficacy of the nation’s vaccines as it aims to inoculate 40 percent of its population by June China is considering mixing different COVID-19 vaccines to improve the relatively low efficacy of its existing options, a top health expert told a conference in Chengdu on Saturday. Authorities have to “consider ways to solve the issue that efficacy rates of existing vaccines are not high,” Chinese media outlet The Paper reported, citing Chinese Center for Disease Control and Prevention Director Gao Fu (高福). His comments mark the first time a top Chinese expert has publicly alluded to the relatively low efficacy of the country’s vaccines, as China forges ahead in its mass vaccination campaign and exports its jabs around the world. China
The Australian government yesterday said that it had decided against buying the single-dose Johnson & Johnson (J&J) COVID-19 vaccine and identified a second case of a rare blood clot likely linked to the AstraZeneca shot. The Australian government had been in talks with the New Jersey-based pharmaceutical giant, which had asked the Australian Therapeutic Goods Administration for provisional registration. However, Australian Minister of Health Greg Hunt ruled out a J&J contract, because its vaccine was similar to the AstraZeneca product, which Australia had already contracted for 53.8 million doses. Hunt said the government was following the advice of Australia’s scientific and technical advisory
The Indonesian government has said it is satisfied with the effectiveness of the Chinese COVID-19 vaccine it has been using, after China’s top disease control official said that current vaccines offer low protection against the novel coronavirus. Siti Nadia Tarmizi, a spokesperson for Indonesia’s COVID-19 vaccine program, on Monday said the WHO had found that the Chinese vaccines had met requirements by being more than 50 percent effective. Clinical trials in Indonesia for the vaccine from Chinese drugmaker Sinovac showed that it was 65 percent effective, she said. “It means ... the ability to form antibodies in our bodies is still very
RSS